Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases

Annals of Hematology

Volumn 84, Issue 8, 2005, Pages 532-537

  Auner, H W ^a,b   Zebisch, A ^a   Ofner, P ^a   Sill, H ^a   Linkesch, W ^a   Krause, R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Autologous stem cell transplantation; High dose chemtherapy; Infection; Risk factor

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; CARBAPENEM; CARMUSTINE; CD34 ANTIGEN; CEPHALOSPORIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MELPHALAN; PAROMOMYCIN; VANCOMYCIN; VORICONAZOLE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; FEBRILE NEUTROPENIA; FEMALE; FEVER; GRAFT INFECTION; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RISK; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; FEMALE; FEVER; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 22344448283     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1025-5     Document Type: Article

References (34)

1. Altes A, Sierra J, Esteve J, Martin-Henao G, Marin P, Sureda A, Briones J, Martino R, Villamor N, Colomer D, Carreras E, Garcia J, Brunet S, Montserrat E (2002) CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: High purging efficiency but increased risk of severe infections. Exp Hematol 30:824-830
2. Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: Comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374-377
3. Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G, Sandherr M, Schuttrumpf S, Sudhoff T, Maschmeyer G (2003) Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 [Suppl 2]:S167-S174
4. Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H, Serke S, Huhn D, Stieger W (1995) Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 13:1328-1335
5. Buzyn A, Tancrede C, Nitenberg G, Cordonnier C (1999) Reflections on gut decontamination in hematology. Clin Microbiol Infect 5:449-456
6. Celebi H, Akan H, Akcaglayan E, Ustun C, Arat M (2000) Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 26:211-214
7. Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, Wagner JL, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger WI, Deeg HJ, Martin PJ, Sanders JE, Storb R, Storek J, Wade J, Siadak M, Flowers ME, Sullivan KM (2003) Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 32:515-522
8. Damiani D, Stocchi R, Masolini P, Michelutti A, Geromin A, Sperotto A, Skert C, Michieli M, Baccarani M, Fanin R (2003) CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection. Ann Oncol 14:475-480
9. de Azevedo AM, Nucci M, Maiolino A, Vigorito AC, Simoes BP, Aranha FJ, Tabak DG, Voltarelli J, de Souza CA (2002) A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 29:745-751
10. De Rosa L, Anghel G, Pandolfi A, Riccardi M, Amodeo R, Majolino I (2004) Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation. Int J Hematol 79:85-91
11. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 15:461-468
12. Demirer T, Ayli M, Dagli M, Haznedar R, Genc Y, Fen T, Dincer S, Unal E, Gunel N, Seyrek E, Ustun T, Ustael N, Yildiz M, Sertkaya D, Ozet G, Muftuoglu O (2002) Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation. Br J Haematol 118:1104-1111
13. Dickson TM, Kusnierz-Glaz CR, Blume KG, Negrin RS, Hu WW, Shizuru JA, Johnston LL, Wong RM, Stockerl-Goldstein KE (1999) Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant 5:299-305
14. Fleming DR, Rayens MK, Garrison J (1997) Impact of obesity on allogeneic stem cell transplant patients: A matched case-controlled study. Am J Med 102:265-268
15. Friedman J, Lazarus HM, Koc ON (2000) Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 26:831-836
16. Fujii K, Aoyama M, Shinagawa K, Matsuo K, Takenaka K, Ikeda K, Kojima K, Ishimaru F, Kiura K, Ueoka H, Niiya K, Tanimoto M, Harada M (2002) Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. Int J Hematol 76:186-191
17. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL (1997) Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204-3213
18. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 25:551-573
19. Ketterer N, Espinouse D, Chomarat M, Dumontet C, Moullet I, Rieux C, Neidhardt-Berard EM, Bouafia F, Coiffier B, Salles G (1999) Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors. Am J Med 106:191-197
20. Kiss JE, Rybka WB, Winkelstein A, deMagalhaes-Silverman M, Lister J, D'Andrea P, Ball ED (1997) Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 19:303-310
21. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J (2000) The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051 1:STN:280:DC%2BD3cvivFCrsg%3D%3D
22. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE (1997) Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 19:143-147
23. Meloni G, Proia A, Capria S, Romano A, Trape G, Trisolini SM, Vignetti M, Mandelli F (2001) Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 28:365-367
24. Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D (1996) Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18:355-359 1:STN:280:ByiD3Mjot10%3D
25. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R, Leoni P (1999) Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 24:1079-1087
26. Perez-Simon JA, Martin A, Caballero D, Corral M, Nieto MJ, Gonzalez M, Vazquez L, Lopez-Berges C, Canizo MC, Mateos MV, Orfao A, San Miguel JF (1999) Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24:1279-1283
27. Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: Comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525-529
28. Scheid C, Draube A, Reiser M, Schulz A, Chemnitz J, Nelles S, Fuchs M, Winter S, Wickramanayake PD, Diehl V, Sohngen D (1999) Using at least 5x10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation. Bone Marrow Transplant 23:1177-1181
29. Sezer O, Eucker J, Bauhuis C, Schweigert M, Luftner D, Kalus U, Spath-Schwalbe E, Arnold R, Possinger K (2000) Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation. Ann Hematol 79:627-630
30. Tarella C, Caracciolo D, Gavarotti P, Argentino C, Zallio F, Corradini P, Novero D, Magnani C, Pileri A (2000) Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 26:1185-1191
31. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQ, Dart GW, Horvath N, Davy ML (1992) Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277-284
32. Van der Meeren A, Vandamme M, Squiban C, Gaugler MH, Mouthon MA (2003) Inflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice. Radiat Res 160:637-646
33. Villela L, Sureda A, Canals C, Sanz MA Jr, Martino R, Valcarcel D, Altes A, Briones J, Gomez M, Brunet S, Sierra J (2003) Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. Haematologica 88:300-305
34. Weaver CH, Schwartzberg LS, Hainsworth J, Greco FA, Li W, Buckner CD, West WH (1997) Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant 19:671-678